Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency

Trial Profile

Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Sep 2017

At a glance

  • Drugs Aspirin/dipyridamole (Primary)
  • Indications Embolism and thrombosis; Vascular graft occlusion
  • Focus Therapeutic Use
  • Acronyms Graft
  • Most Recent Events

    • 21 May 2009 Results published in the New England Journal of Medicine.
    • 30 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top